Phenylethyl Alcohol

Phenylethyl Alcohol

SCHEMBL11422845

CC(C)O.OCCc1ccccc1

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.76
TRPA1 O75762 3/20 0.48
CA2 P00918 1/20 0.46
TSHR P16473 2/20 0.46
ALDH1A1 P00352 2/20 0.45
CYP4F2 P78329 2/20 0.44
CYP4A11 Q02928 2/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
CASP1 P29466 1/20 0.44
HSD17B10 Q99714 1/20 0.44
SIGMAR1 Q99720 2/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylethyl Alcohol SCHEMBL28557546 0.93 TDP1 (0.73) TDP1TRPA1CA2TSHRALDH1A1
Phenylethyl Alcohol SCHEMBL27856433 0.91 TDP1 (0.70) TDP1TRPA1CA2TSHRALDH1A1
Phenylethyl Alcohol SCHEMBL10904935 0.87 TDP1 (0.89) TDP1CA2TSHRALDH1A1CYP4F2
Phenylethyl Alcohol SCHEMBL8968173 0.87 TDP1 (1.00) TDP1CA2TSHRALDH1A1CYP4F2
Phenylethyl Alcohol SCHEMBL21905692 0.87 TDP1 (0.64) TDP1TSHRALDH1A1CYP4F2CYP4A11
Phenylethyl Alcohol SCHEMBL11450063 0.87 TDP1 (1.00) TDP1CA2TSHRALDH1A1CYP4F2
Phenyl Ethanol SCHEMBL8145962 0.87 TDP1 (0.64) TDP1TRPA1ALDH1A1KDM4E
Phenylethyl Alcohol SCHEMBL8160725 0.87 TDP1 (0.64) TDP1TRPA1TSHRHPGDSIGMAR1
Phenylethyl Alcohol SCHEMBL1867158 0.87 TDP1 (1.00) TDP1CA2TSHRALDH1A1CYP4F2
Phenylethyl Alcohol SCHEMBL1838 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112479875-A Method for preparing alpha-oxo-carboxylic ester by selective oxidation of alpha-hydroxy-carboxylic ester 厦门大学 2021-03-12 CN disclosed
US-9102665-B2 Cysteinyl leukotriene antagonists SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) 2015-08-11 US disclosed
US-20140155596-A1 CYSTEINYL LEUKOTRIENE ANTAGONISTS SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) 2014-06-05 US disclosed
US-4213972-A BACTERICIDES ABBOTT LABORATORIES (US) 1980-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140155596-A1 CYSTEINYL LEUKOTRIENE ANTAGONISTS LTC4S, CYSLTR2, CYSLTR1 TDP1 4737/4885TRPA1 179/4885CA2 1465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.